Ilia Zhidkov, Ph.D. is the VP of computational platform at Evogene Ltd. (Nasdaq/TASE: EVGN), a computational chemistry company specializing in the generative design of small molecules for the pharmaceutical and agricultural industries.
Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities....
